Premium
UCP 2 gene polymorphisms in obesity and diabetes, and the role of UCP 2 in cancer
Author(s) -
Li Jinran,
Jiang Rihua,
Cong Xianling,
Zhao Yunfeng
Publication year - 2019
Publication title -
febs letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.593
H-Index - 257
eISSN - 1873-3468
pISSN - 0014-5793
DOI - 10.1002/1873-3468.13546
Subject(s) - mitochondrion , biology , cancer , cancer cell , inner mitochondrial membrane , diabetes mellitus , insulin resistance , oxidative stress , endocrinology , medicine , microbiology and biotechnology , genetics
Mitochondria are the primary sites for ATP synthesis and free radical generation in organisms. Abnormal mitochondrial metabolism contributes to many diseases, including obesity, diabetes and cancer. UCP 2 is an ion/anion transporter located in mitochondrial inner membrane, and has a crucial role in regulating oxidative stress, cellular metabolism, cell proliferation and cell death. Polymorphisms of the UCP 2 gene have been associated with diabetes and obesity because UCP 2 is involved in energy expenditure and insulin secretion. Moreover, UCP 2 gene expression is often amplified in cancers, and increased UCP 2 expression contributes to cancer growth, cancer metabolism, anti‐apoptosis and drug resistance. The present review summarizes the latest findings of UCP 2 with respect to obesity, diabetes and cancer.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom